Enveric Biosciences upsizes ATM offering by $2.425M; prior sales total $4.48M

Enveric Biosciences, Inc.

Filed prospectus supplement to sell up to $2,425,000 of common stock under existing ATM agreement.
Prior ATM sales through H.C. Wainwright totaled $4,483,711.04.
Legal opinion from Greenberg Traurig filed as Exhibit 5.1.

item 8.01 item 9.01

Enveric Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-027976

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.